Published in J Pers Med on May 02, 2012
Highly rapid amplification-free and quantitative DNA imaging assay. Sci Rep (2013) 0.88
Real-time duplex applications of loop-mediated AMPlification (LAMP) by assimilating probes. Int J Mol Sci (2015) 0.88
Diagnostics for Developing Countries. Diagnostics (Basel) (2015) 0.83
Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells. Front Immunol (2014) 0.77
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med (2006) 23.62
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis (2007) 5.39
An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis (2010) 4.06
Genomics, health care, and society. N Engl J Med (2011) 3.57
Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC). Arch Microbiol (2011) 3.55
Preparing for precision medicine. N Engl J Med (2012) 3.34
Genomic and personalized medicine: foundations and applications. Transl Res (2009) 3.24
Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med (2000) 3.19
Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect (2006) 3.14
MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol (2010) 2.79
Emerging infections: a perpetual challenge. Lancet Infect Dis (2008) 2.75
Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol (2011) 2.57
Microfluidic platforms for lab-on-a-chip applications. Lab Chip (2007) 2.56
Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diagn (2010) 2.47
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med (2011) 2.44
PCR microfluidic devices for DNA amplification. Biotechnol Adv (2005) 2.20
Personalized medicine: progress and promise. Annu Rev Genomics Hum Genet (2011) 2.06
Centrifugal microfluidics for biomedical applications. Lab Chip (2010) 1.94
Lab on a CD. Annu Rev Biomed Eng (2006) 1.94
New technology for rapid molecular diagnosis of bloodstream infections. Expert Rev Mol Diagn (2010) 1.94
Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother (2011) 1.93
The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid. Clin Infect Dis (2004) 1.87
Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin Infect Dis (2011) 1.82
Rapid methods for diagnosis of bloodstream infections. Clin Chem Lab Med (2008) 1.79
The impact of anti-infective drug shortages on hospitals in the United States: trends and causes. Clin Infect Dis (2012) 1.78
Polymer microfabrication technologies for microfluidic systems. Anal Bioanal Chem (2007) 1.75
Evidence from multiplex molecular assays for complex multipathogen interactions in acute respiratory infections. J Clin Microbiol (2007) 1.71
Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev (2009) 1.70
Microfluidic DNA amplification--a review. Anal Chim Acta (2009) 1.67
Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis (2007) 1.60
Point of care testing. Clin Lab Med (2007) 1.53
Near-patient testing--point-of-care or point of costs and convenience? Br J Anaesth (2003) 1.48
One-step pathogen specific DNA extraction from whole blood on a centrifugal microfluidic device. Lab Chip (2007) 1.44
Microfluidic sample preparation: cell lysis and nucleic acid purification. Integr Biol (Camb) (2009) 1.44
Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses? Antimicrob Agents Chemother (2005) 1.42
Application and use of various mass spectrometry methods in clinical microbiology. Clin Microbiol Infect (2010) 1.34
Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Crit Care (2010) 1.33
The Personalized Medicine Coalition: goals and strategies. Am J Pharmacogenomics (2005) 1.32
Diagnosing infections--current and anticipated technologies for point-of-care diagnostics and home-based testing. Clin Microbiol Infect (2010) 1.27
Rapid prototyping polymers for microfluidic devices and high pressure injections. Lab Chip (2011) 1.26
Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model. Pharmacoeconomics (2010) 1.22
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid. Eur J Clin Pharmacol (2007) 1.20
Revolutionizing clinical microbiology laboratory organization in hospitals with in situ point-of-care. PLoS One (2011) 1.19
Highly-integrated lab-on-chip system for point-of-care multiparameter analysis. Lab Chip (2011) 1.18
Current applications and future trends of molecular diagnostics in clinical bacteriology. Anal Bioanal Chem (2009) 1.17
Conventional and molecular techniques for the early diagnosis of bacteraemia. Int J Antimicrob Agents (2010) 1.16
Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from intensive care unit patients. J Clin Microbiol (2010) 1.13
Development of rapid, automated diagnostics for infectious disease: advances and challenges. Expert Rev Med Devices (2009) 1.12
Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia? Clin Infect Dis (2011) 1.11
Next-generation integrated microfluidic circuits. Lab Chip (2011) 1.09
Genetic analysis of H1N1 influenza virus from throat swab samples in a microfluidic system for point-of-care diagnostics. J Am Chem Soc (2011) 1.09
Antimicrobial stewardship: bridging the gap between quality care and cost. Curr Opin Infect Dis (2011) 1.08
HIV-1 drug resistance genotyping quality assessment: results of the ENVA7 Genotyping Proficiency Programme. J Clin Virol (2008) 1.08
Revisiting "older" antimicrobials in the era of multidrug resistance. Pharmacotherapy (2011) 1.08
Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia. J Hosp Med (2011) 1.04
Current challenges in the management of the infected patient. Curr Opin Infect Dis (2011) 1.02
Purification of nucleic acids in microfluidic devices. Anal Chem (2008) 1.02
The antibiotic R&D pipeline: an update. Curr Opin Microbiol (2011) 1.02
Development and evaluation of a novel multiplex PCR technology for molecular differential detection of bacterial respiratory disease pathogens. J Clin Microbiol (2008) 1.01
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends Microbiol (2010) 1.01
Routine use of point-of-care tests: usefulness and application in clinical microbiology. Clin Microbiol Infect (2010) 0.99
Molecular diagnostics of sepsis--where are we today? Int J Med Microbiol (2010) 0.99
Molecular diagnostics of medically important bacterial infections. Curr Issues Mol Biol (2007) 0.99
Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside. Curr Opin Infect Dis (2010) 0.98
Point-of-care testing, medical error, and patient safety: a 2007 assessment. Clin Chem Lab Med (2007) 0.98
Comparative evaluation of the AccuProbe Group B Streptococcus Culture Test, the BD GeneOhm Strep B assay, and culture for detection of group B streptococci in pregnant women. J Clin Microbiol (2009) 0.98
Nucleic acids as viability markers for bacteria detection using molecular tools. Future Microbiol (2009) 0.97
Invited Review Article: Review of centrifugal microfluidic and bio-optical disks. Rev Sci Instrum (2009) 0.96
Microfluidic DNA microarray analysis: a review. Anal Chim Acta (2010) 0.96
Point-of-care testing and molecular diagnostics: miniaturization required. Clin Lab Med (2009) 0.95
Validation of a centrifugal microfluidic sample lysis and homogenization platform for nucleic acid extraction with clinical samples. Lab Chip (2009) 0.94
Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome. Medicine (Baltimore) (2011) 0.93
Intact cell MALDI-TOF mass spectrometry-based approaches for the diagnosis of bloodstream infections. Expert Rev Mol Diagn (2011) 0.92
Modifications of commercial toxigenic Clostridium difficile PCR resulting in improved economy and workflow efficiency. J Clin Microbiol (2011) 0.91
Diagnostic testing or empirical therapy for patients hospitalized with suspected influenza: what to do? Clin Infect Dis (2009) 0.91
Current impact of gene technology on healthcare. A map of economic assessments. Health Policy (2006) 0.91
An unmet medical need: rapid molecular diagnostics tests for respiratory tract infections. Clin Infect Dis (2011) 0.89
Miniaturization of molecular biological techniques for gene assay. Analyst (2010) 0.89
Hospitalizations for extreme conditions mean extreme expenses, study verifies. JAMA (2010) 0.88
A plastic, disposable microfluidic flow cell for coupled on-chip PCR and microarray detection of infectious agents. Biomed Microdevices (2012) 0.87
The clinical utility of precision medicine: properly assessing the value of emerging diagnostic tests. Clin Pharmacol Ther (2010) 0.86
Point-of-care diagnostics: an advancing sector with nontechnical issues. Expert Rev Mol Diagn (2008) 0.85
Characteristics and outcomes of polymicrobial bloodstream infections in the emergency department: A matched case-control study. Acad Emerg Med (2010) 0.84
Improving the power of diagnostics in the era of targeted therapy and personalized healthcare. Curr Opin Drug Discov Devel (2010) 0.84
Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine. Expert Rev Mol Diagn (2006) 0.84
Effect of screening for methicillin-resistant Staphylococcus aureus carriage by polymerase chain reaction on the duration of unnecessary preemptive contact isolation. Infect Control Hosp Epidemiol (2008) 0.83
Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind. J Intensive Care Med (2010) 0.82
Point of care strategy for rapid diagnosis of novel A/H1N1 influenza virus. PLoS One (2010) 0.82
Diagnosing emerging and reemerging infectious diseases: the pivotal role of the pathologist. Arch Pathol Lab Med (2011) 0.82
A multilevel Lab on chip platform for DNA analysis. Biomed Microdevices (2011) 0.82
Evaluation of the BD GeneOhm MRSA and VanR Assays as a Rapid Screening Tool for Detection of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in a Tertiary Hospital in Saudi Arabia. Int J Microbiol (2011) 0.82
Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays. Diagn Microbiol Infect Dis (2011) 0.82
The current status and future potential of personalized diagnostics: Streamlining a customized process. Biotechnol Annu Rev (2008) 0.81
Is there a niche for DNA microarrays in molecular diagnostics? Expert Rev Mol Diagn (2010) 0.81
Feasibility of methods based on nucleic acid amplification techniques to fulfil the requirements for microbiological analysis of water quality. J Appl Microbiol (2010) 0.81
Revolutionizing the practice of medicine through rapid (< 1h) DNA-based diagnostics. Clin Invest Med (2008) 0.81
Direct immobilization of DNA probes on non-modified plastics by UV irradiation and integration in microfluidic devices for rapid bioassay. Anal Bioanal Chem (2011) 0.81
Wireless induction heating in a microfluidic device for cell lysis. Lab Chip (2010) 0.80
Microfluidic devices for diagnostic applications. Expert Rev Mol Diagn (2011) 0.80